Li et al. demonstrated that MAP4K2 plays a critical role in the survival and proliferation of RAS-mutant multiple myeloma (MM) cells, a malignancy of terminally differentiated plasma cells in the bone marrow that commonly leads to anemia, bone destruction and kidney dysfunction35,36. The gene discussed is MAP4K2; the disease is Miyoshi myopathy.